| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c16d2144a81bfa32a665dca1e93c3d37 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F17-18 |
| filingDate |
2010-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8218318ed7e33414f4471ffb9a7c3daf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ddea0ec3ae1f9a6bdf1ccb37bdb56ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6404b5d790f7421a883112d67e690bb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41b3138c42f999815768b5dfb8cd1cee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_224ad91782b7d0fb914016761ce6828e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_825879dd45d114af905995b3fbc11b41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4a23d3230ea7f4f692d3905f3bbc8af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e00cadfe2045c6efbcd0b446c1f2bc0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e0b16ea3fd0e4483986f387727a0a1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a55cc07f494a2cb598205ed8e6e5c9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bf5d23c7835d3df29b770fea5b6d9ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfeb09bd793da6678e583256ee049f69 |
| publicationDate |
2012-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120031740-A |
| titleOfInvention |
Kits and Methods for Predicting Anticancer Drug Sensitivity in Gastric Cancer Patients |
| abstract |
Kits and methods for predicting anticancer drug sensitivity in gastric cancer patients. According to the kit and method for predicting the anticancer agent sensitivity of the gastric cancer patient according to an embodiment, the sensitivity to the anticancer agent may be efficiently predicted from a biological sample derived from the gastric cancer patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014116276-A1 |
| priorityDate |
2010-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |